Albany Molecular Research

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Solutions (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing. Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API Manufacturing supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, biologics, peptides, steroids, and cytotoxic compounds. Drug Product Manufacturing supports development through commercial scale production of complex liquid-filled and lyophilized parenteral formulations. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal) and Facebook (@AlbanyMolecularResearchInc).
Type
Public
HQ
Albany, US
Founded
1991
Employees
2,220 (est)
Albany Molecular Research was founded in 1991 and is headquartered in Albany, US

Albany Molecular Research Locations

Albany, US

Albany Molecular Research Metrics

Albany Molecular Research Summary

Market capitalization

$712 M

Closing share price

$17.2
Albany Molecular Research's latest market capitalization is $712 M.

Albany Molecular Research Market Value History

Albany Molecular Research Online Presence

Albany Molecular Research News

Albany Molecular Research Company Life

You may also be interested in